It is indeed surprising that loss of function of UBA1 would lead to clonal advantage, as UPS has been the target of multiple anti-cancer drugs [5–9], and UBA1 itself was identified as cancer dependency in multiple studies [10–12]. This evidence concerns the gene UBA1 and cancer.